Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1139040.RArK0sb3V3ODgDxsXN2J0niH4RMq9RUetIE2BLU4KKw_M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1139040.RArK0sb3V3ODgDxsXN2J0niH4RMq9RUetIE2BLU4KKw_M130_assertion type Assertion NP1139040.RArK0sb3V3ODgDxsXN2J0niH4RMq9RUetIE2BLU4KKw_M130_head.
- NP1139040.RArK0sb3V3ODgDxsXN2J0niH4RMq9RUetIE2BLU4KKw_M130_assertion description "[Taken together, our data indicate that IL-17 contributed to ovarian cancer malignancy through promoting the self-renewal of CD133(+)CSLCs and that IL-17 and its signaling pathway might serve as therapeutic targets for the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1139040.RArK0sb3V3ODgDxsXN2J0niH4RMq9RUetIE2BLU4KKw_M130_provenance.
- NP1139040.RArK0sb3V3ODgDxsXN2J0niH4RMq9RUetIE2BLU4KKw_M130_assertion evidence source_evidence_literature NP1139040.RArK0sb3V3ODgDxsXN2J0niH4RMq9RUetIE2BLU4KKw_M130_provenance.
- NP1139040.RArK0sb3V3ODgDxsXN2J0niH4RMq9RUetIE2BLU4KKw_M130_assertion SIO_000772 24362529 NP1139040.RArK0sb3V3ODgDxsXN2J0niH4RMq9RUetIE2BLU4KKw_M130_provenance.
- NP1139040.RArK0sb3V3ODgDxsXN2J0niH4RMq9RUetIE2BLU4KKw_M130_assertion wasDerivedFrom befree-2016 NP1139040.RArK0sb3V3ODgDxsXN2J0niH4RMq9RUetIE2BLU4KKw_M130_provenance.
- NP1139040.RArK0sb3V3ODgDxsXN2J0niH4RMq9RUetIE2BLU4KKw_M130_assertion wasGeneratedBy ECO_0000203 NP1139040.RArK0sb3V3ODgDxsXN2J0niH4RMq9RUetIE2BLU4KKw_M130_provenance.